These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2707062)

  • 1. Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection.
    Yew WW; Kwan SY; Ma WK; Aung-khin M; Mok CK
    Chest; 1989 May; 95(5):1051-5. PubMed ID: 2707062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single daily-dose ofloxacin monotherapy for Mycobacterium fortuitum sternotomy infection.
    Yew WW; Kwan SY; Ma WK; Khin MA; Mok CK
    Chest; 1989 Nov; 96(5):1150-2. PubMed ID: 2805845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of ofloxacin and other agents against mycobacterial isolates from postoperative sternotomy wounds.
    Yew WW; Kwan SY; Ma WK; Lui KS; Aung MK
    Clin Ther; 1989; 11(6):775-85. PubMed ID: 2611821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ; Swenson JM; Silcox VA; Bullen MG
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin therapy of Mycobacterium fortuitum infection: further experience.
    Yew WW; Kwan SY; Ma WK; Lui KS; Suen HC
    J Antimicrob Chemother; 1990 May; 25(5):880-1. PubMed ID: 2373673
    [No Abstract]   [Full Text] [Related]  

  • 6. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.
    Tsui SY; Yew WW; Li MS; Chan CY; Cheng AF
    Antimicrob Agents Chemother; 1993 May; 37(5):1001-3. PubMed ID: 8517688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR; Pankey GA; Wallace RJ; Jones DB
    Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium fortuitum infections of the mediastinum.
    Sethi GK; Simons WJ; Scott SM
    J Cardiovasc Surg (Torino); 1985; 26(3):307-9. PubMed ID: 3997975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive surgical management of cutaneous Mycobacterium fortuitum infection.
    Madjar DD; Carvallo E; Proper SA; Fenske NA
    J Dermatol Surg Oncol; 1985 Jul; 11(7):708-12. PubMed ID: 4008739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amikacin treatment for Mycobacterium marinum infection.
    Arai H; Nakajima H; Naito S; Kaminaga Y; Nagai R
    J Dermatol; 1986 Oct; 13(5):385-9. PubMed ID: 3546444
    [No Abstract]   [Full Text] [Related]  

  • 11. Port-site infections by nontuberculous mycobacterium: A retrospective clinico-microbiological study.
    Ghosh R; Das S; De A; Kela H; Saha ML; Maiti PK
    Int J Mycobacteriol; 2017; 6(1):34-37. PubMed ID: 28317802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Mycobacterium fortuitum infection.
    Oren B; Raz R; Hass H
    Infection; 1990; 18(2):105-6. PubMed ID: 2332244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
    Wallace RJ; Bedsole G; Sumter G; Sanders CV; Steele LC; Brown BA; Smith J; Graham DR
    Antimicrob Agents Chemother; 1990 Jan; 34(1):65-70. PubMed ID: 2327761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium fortuitum wound infection following laparoscopy.
    Sethi S; Sharma M; Ray P; Singh M; Gupta A
    Indian J Med Res; 2001 Mar; 113():83-4. PubMed ID: 11525156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the in vitro susceptibility of 220 Mycobacterium fortuitum isolates to ten antimicrobial agents.
    Hernández AM; Arias A; Felipe A; Alvarez R; Sierra A
    J Chemother; 1995 Dec; 7(6):503-8. PubMed ID: 8667033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postcesarean section wound infection caused by Mycobacterium massiliense.
    Wu TS; Yang CH; Brown-Elliott BA; Chao AS; Leu HS; Wu TL; Lin CS; Griffith DE; Chiu CH
    J Microbiol Immunol Infect; 2016 Dec; 49(6):955-961. PubMed ID: 26350122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical wound infection following open humeral fracture caused by Mycobacterium houstonense: a case report.
    Tian L; Zhang Z; Chen Z; Sun Z
    BMC Infect Dis; 2019 Apr; 19(1):333. PubMed ID: 31014284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management.
    Girgis DO; Karp CL; Miller D
    Clin Exp Ophthalmol; 2012 Jul; 40(5):467-75. PubMed ID: 21902780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.